Your browser doesn't support javascript.
General Anesthesia for Pediatric Radiation Therapy in the Era of COVID-19.
LaRiviere, Michael J; Shah, Yash B; Cummings, Elizabeth R; Clegg, Kelly; Doucette, Abigail; Struyk, Brian P; Lustig, Robert A; Kurtz, Goldie; Hill-Kayser, Christine E.
  • LaRiviere MJ; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Shah YB; Department of Radiation Oncology, Children's Hospital of Pennsylvania, Philadelphia, Pennsylvania.
  • Cummings ER; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Clegg K; Department of Radiation Oncology, Children's Hospital of Pennsylvania, Philadelphia, Pennsylvania.
  • Doucette A; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Struyk BP; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Lustig RA; Department of Radiation Oncology, Children's Hospital of Pennsylvania, Philadelphia, Pennsylvania.
  • Kurtz G; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Hill-Kayser CE; Department of Radiation Oncology, Children's Hospital of Pennsylvania, Philadelphia, Pennsylvania.
Adv Radiat Oncol ; 7(4): 100929, 2022.
Article in English | MEDLINE | ID: covidwho-1797319
ABSTRACT

Purpose:

Managing pediatric patients requiring daily general anesthesia (GA) for radiation therapy (RT) in the setting of COVID-19 is complex, owing to the aerosolizing nature of GA procedures, the risk of cardiopulmonary complications for infected patients, and the treatment of immunocompromised oncology patients in a busy, densely populated radiation oncology clinic. Methods and Materials We developed an institutional protocol to define procedures for COVID-19 testing and protection of patients, caregivers, and staff, hypothesizing that this protocol would allow patients requiring GA to be safely treated, minimizing COVID-19 transmission risk to both patients and staff, and at the same time maintaining pre-COVID-19 patient volumes. All patients underwent COVID-19 testing before their first treatment and thrice weekly during treatment. For patients who tested positive for COVID-19, RT was delivered in the last end-of-day treatment appointment. A negative pressure room was used for GA induction and recovery, and separate physician/nurse teams were designated for in-room versus out-of-room patient management.

Results:

Seventy-eight pediatric patients received RT under GA, versus 69 over the same prior year timeframe, and 2 patients received 2 courses of RT under GA, for a total of 80 courses. The mean age was 4.9 years (range, 0.5-19.0 years) and 41 of 78 (52.6%) were male. Two patients (2.6%) received 2 courses of RT under GA, establishing a total of 80 courses. The mean number of treatment fractions was 22.2 (range, 1-40). Two of 78 patients (2.6%) tested positive for COVID-19; both were asymptomatic. Both patients completed treatment as prescribed. Neither patient developed cardiopulmonary symptoms complicating anesthesia, and neither patient experienced grade 3+ acute radiation toxicity.

Conclusions:

With careful multidisciplinary planning to mitigate COVID-19 risk, pediatric RT with GA was carried out for a large patient volume without widespread infection and without increased toxic effects from either GA or RT.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Adv Radiat Oncol Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Adv Radiat Oncol Year: 2022 Document Type: Article